Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 24 07 2020
accepted: 30 09 2020
pubmed: 11 10 2020
medline: 14 1 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

Can a patient diagnosed with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) be infected again? This question is still unsolved. We tried to analyze local and literature cases with a positive respiratory swab after recovery. We collected data from symptomatic patients diagnosed with SARS-CoV-2 infection in the Italian Umbria Region that, after recovery, were again positive for SARS-CoV-2 in respiratory tract specimens. Samples were also assessed for infectivity in vitro. A systematic review of similar cases reported in the literature was performed. The study population was composed of 9 patients during a 4-month study period. Among the new positive samples, six were inoculated in Vero-E6 cells and showed no growth and negative molecular test in culture supernatants. All patients were positive for IgG against SARS-CoV-2 nucleoprotein and/or S protein. Conducting a review of the literature, 1350 similar cases have been found. The presumptive reactivation occurred in 34.5 days on average (standard deviation, SD, 18.7 days) after COVID-19 onset, when the 5.6% of patients presented fever and the 27.6% symptoms. The outcome was favorable in 96.7% of patients, while the 1.1% of them were still hospitalized at the time of data collection and the 2.1% died. Several hypotheses have been formulated to explain new positive respiratory samples after confirmed negativity. According to this study, the phenomenon seems to be due to the prolonged detection of SARS-CoV-2 RNA traces in respiratory samples of recovered patients. The failure of the virus to replicate in vitro suggests its inability to replicate in vivo.

Identifiants

pubmed: 33037944
doi: 10.1007/s10096-020-04057-6
pii: 10.1007/s10096-020-04057-6
pmc: PMC7547550
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Case Reports Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-12

Références

Sci Rep. 2020 Jul 17;10(1):11887
pubmed: 32681141
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
New Microbes New Infect. 2020 Jul 23;37:100732
pubmed: 32789020
Am J Emerg Med. 2021 Jan;39:256.e1-256.e3
pubmed: 32703607
Euro Surveill. 2020 Mar;25(11):
pubmed: 32209164
J Med Virol. 2021 Jan;93(1):262-274
pubmed: 32609390
Int J Biol Sci. 2020 Mar 15;16(10):1678-1685
pubmed: 32226285
Clin Microbiol Infect. 2020 Aug;26(8):1115-1117
pubmed: 32360448
Clin Rheumatol. 2020 Sep;39(9):2803-2810
pubmed: 32725351
Front Oncol. 2020 Jul 03;10:1272
pubmed: 32719750
J Infect. 2020 Jul;81(1):147-178
pubmed: 32289343
Infection. 2021 Feb;49(1):57-61
pubmed: 32725596
Quant Imaging Med Surg. 2020 Jul;10(7):1572-1575
pubmed: 32676376
J Med Virol. 2020 Nov;92(11):2887-2890
pubmed: 32779765
Clin Pediatr (Phila). 2020 Sep;59(9-10):929-932
pubmed: 32462940
PLoS Negl Trop Dis. 2020 Aug 31;14(8):e0008648
pubmed: 32866168
J Med Virol. 2020 Nov;92(11):2847-2851
pubmed: 32558947
Infect Dis (Lond). 2020 Aug;52(8):581-582
pubmed: 32434442
Eur J Clin Microbiol Infect Dis. 2021 Feb;40(2):413-417
pubmed: 32865669
Int J Infect Dis. 2020 Apr;93:297-299
pubmed: 32147538
J Med Virol. 2020 Nov;92(11):2298-2301
pubmed: 32369214
J Infect Dis. 2020 Nov 9;222(11):1784-1788
pubmed: 32491178
EBioMedicine. 2020 Sep;59:102960
pubmed: 32853988
Infection. 2020 Dec;48(6):965-967
pubmed: 32415334
Epidemiol Infect. 2020 Jun 03;148:e108
pubmed: 32487271
J Med Virol. 2020 Oct;92(10):2159-2164
pubmed: 32410245
QJM. 2020 Sep 1;113(9):657-665
pubmed: 32442308
Rev Clin Esp. 2020 Nov;220(8):524-526
pubmed: 33994575
Am J Hematol. 2020 Jul;95(7):834-847
pubmed: 32282949
J Infect. 2020 Aug;81(2):e49-e52
pubmed: 32335176
J Infect. 2020 May;80(5):e14-e17
pubmed: 32171867
Infect Dis (Lond). 2020 Oct;52(10):743-745
pubmed: 32579420
J Infect. 2020 Sep;81(3):e90-e92
pubmed: 32574567
J Infect. 2020 Nov;81(5):816-846
pubmed: 32619697
J Med Virol. 2021 Feb;93(2):655-656
pubmed: 32797634
J Infect. 2020 Dec;81(6):e1-e3
pubmed: 32853596
Oral Dis. 2021 Apr;27 Suppl 3:707-709
pubmed: 32333518
J Infect. 2020 Jun;80(6):666-670
pubmed: 32283165
Ann Am Thorac Soc. 2020 Oct;17(10):1231-1237
pubmed: 32692945
J Thorac Dis. 2020 Jun;12(6):3439-3441
pubmed: 32642274
J Med Virol. 2021 Jan;93(1):97-98
pubmed: 32525558
Osong Public Health Res Perspect. 2020 Jun;11(3):112-117
pubmed: 32528816
Respir Med Case Rep. 2020 Jul 10;31:101152
pubmed: 32704471
Br J Hosp Med (Lond). 2020 Apr 2;81(4):1-2
pubmed: 32339007
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Ann Med. 2021 Dec;53(1):34-42
pubmed: 32808808
J Med Virol. 2021 Feb;93(2):592-594
pubmed: 32697372
J Am Geriatr Soc. 2020 Oct;68(10):2179-2183
pubmed: 32638347
J Med Virol. 2020 Sep;92(9):1681-1683
pubmed: 32330293
J Clin Lab Anal. 2020 Jul;34(7):e23392
pubmed: 32506726
Eur J Radiol. 2020 Jun;127:109010
pubmed: 32334369
J Med Virol. 2020 Oct;92(10):1938-1947
pubmed: 32311109
Ann Intern Med. 2020 Jun 16;172(12):832-834
pubmed: 32227141
Biochem Biophys Res Commun. 2005 Apr 15;329(3):1147-51
pubmed: 15752773
J Med Virol. 2020 Oct;92(10):2146-2151
pubmed: 32401361
Diabetes Res Clin Pract. 2020 Aug;166:108300
pubmed: 32663490
Int J Infect Dis. 2020 Aug;97:212-214
pubmed: 32200109
J Med Virol. 2021 Jan;93(1):541-545
pubmed: 32639581
J Med Virol. 2020 Nov;92(11):2384-2386
pubmed: 32470172
Pediatr Int. 2020 Jul;62(7):879-881
pubmed: 32421910
Front Med (Lausanne). 2020 Jun 23;7:349
pubmed: 32656223
Pathog Dis. 2020 Jun 1;78(4):
pubmed: 32592396
EClinicalMedicine. 2020 Sep;26:100492
pubmed: 32864590
BMC Infect Dis. 2020 Jul 11;20(1):500
pubmed: 32652938
J Infect. 2020 Dec;81(6):979-997
pubmed: 32810521
Environ Microbiol. 2020 Aug;22(8):3588-3592
pubmed: 32632947
Pediatr Infect Dis J. 2020 Jun;39(6):e69-e70
pubmed: 32282658
Lancet Infect Dis. 2020 Sep;20(9):1004-1005
pubmed: 32645295
Virus Res. 2020 Sep;286:198047
pubmed: 32522535
Quant Imaging Med Surg. 2020 Jun;10(6):1318-1324
pubmed: 32550140
Medicine (Baltimore). 2020 Aug 21;99(34):e21865
pubmed: 32846839
J Gen Intern Med. 2020 Jul;35(7):2205-2206
pubmed: 32314129
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183934
J Microbiol Immunol Infect. 2021 Feb;54(1):101-104
pubmed: 32807688
Biochem Med (Zagreb). 2020 Oct 15;30(3):030401
pubmed: 32774117
Hemodial Int. 2020 Oct;24(4):E50-E54
pubmed: 32743901
Cureus. 2020 Mar 26;12(3):e7423
pubmed: 32337143
J Infect Public Health. 2020 Jul;13(7):932-934
pubmed: 32540264
Eur J Radiol. 2020 Aug;129:109122
pubmed: 32540583
J Infect. 2020 Aug;81(2):e72-e73
pubmed: 32389787
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304
Am J Infect Control. 2020 Jun;48(6):725-726
pubmed: 32317126
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
Clin Microbiol Infect. 2020 Nov;26(11):1556.e1-1556.e6
pubmed: 32653662
Ann Rheum Dis. 2021 Jun;80(6):e87
pubmed: 32606044
New Microbes New Infect. 2020 Sep;37:100748
pubmed: 32843984

Auteurs

Anna Gidari (A)

Department of Medicine, Clinic of Infectious Diseases, "Santa Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy. anna.gidari@studenti.unipg.it.

Marco Nofri (M)

Department of Medicine, Clinic of Infectious Diseases, "Santa Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy.

Luca Saccarelli (L)

Department of Anesthesiology, Intensive Care and Pain therapy Center, "Santa Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy.

Sabrina Bastianelli (S)

Department of Medicine, Clinic of Infectious Diseases, "Santa Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy.

Samuele Sabbatini (S)

Department of Medicine, Medical Microbiology Section, University of Perugia, Perugia, Italy.

Silvia Bozza (S)

Department of Medicine, Medical Microbiology Section, University of Perugia, Perugia, Italy.

Barbara Camilloni (B)

Department of Medicine, Medical Microbiology Section, University of Perugia, Perugia, Italy.

Igino Fusco-Moffa (I)

Department of Prevention, Local Health Unit Umbria 1, Travel Medicine Unit, Perugia, Italy.

Claudia Monari (C)

Department of Medicine, Medical Microbiology Section, University of Perugia, Perugia, Italy.

Edoardo De Robertis (E)

Department of Anesthesiology, Intensive Care and Pain therapy Center, "Santa Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy.

Antonella Mencacci (A)

Department of Medicine, Medical Microbiology Section, University of Perugia, Perugia, Italy.

Daniela Francisci (D)

Department of Medicine, Clinic of Infectious Diseases, "Santa Maria della Misericordia" Hospital, University of Perugia, Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH